Navigating the digital pathway in the NHS with DigitalHealth.London
Our acceptance into DigitalHealth.London’s Accelerator programme, gave us the opportunity to significantly increase our credibility and visibility with NHS stakeholders.…
Chelsea and Westminster hospitals launch clinical trial to remotely monitor stroke risk
As part of their CW Innovation programme, the Chelsea and Westminster Hospital NHS Foundation Trust and its charity CW+ started…
Our UK lead Felicia Vaz on why integrated care is the future
The AHSN Network - the UK body that connects the NHS and academic organisations, local authorities, the third sector and…
Three UK hospitals prescribe remote monitoring for post-stroke patients
Over at Barking, Havering and Redbridge University Hospitals, a clinical trial has been conducted where post-stroke patients tested themselves at…
FibriCheck receives perfect DTAC rating
FibriCheck is proud to announce that in addition to being among the first to go through Orcha’s rigorous assessment process,…
FibriCheck wins ‘Good health and well-being’ award at the WSA
We are proud to have won the award in the ‘Good health and well-being’ category at this year’s World Summit…
FibriCheck’s pulse beating stronger than ever in 2021
We started 2021 off strong with a new investment round. The newly invested 9 million euros allowed us to further…
FibriCheck statement on Log4j vulnerability
FibriCheck is aware of the Log4j zero-day vulnerability in the Java logging framework. This vulnerability is being tracked as CVE-2021-442281/2…
World Heart Rhythm Week: listening to your heart saves lives
Atrial fibrillation (AF) is the most common heart rhythm disorder. People as young as 40 have a 1 in 4…
BeHRA and FibriCheck join forces for Heart Rhythm Week
On the occasion of Heart Rhythm Week, the Belgian Heart Rhythm Association (BeHRA) in association with FibriCheck is organising a…
FibriCheck brings TGA-certified heart health app to Australia
FibriCheck, the app capable of detecting heart rhythm disorders like atrial fibrillation, is now available in Australia for use with…
Daiichi Sankyo and FibriCheck announce digital partnership set to transform at-home AF detection and diagnosis
Atrial Fibrillation (AF) is one of the leading causes of stroke and often goes undiagnosed due to lack of symptoms.1…